Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

European journal of neurology·2026
Same author

Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Muscle & nerve·2026
Same author

Microstructure-informed deep learning improves thalamic atrophy segmentation and clinical associations in multiple sclerosis and related neuroimmunological diseases.

NeuroImage. Clinical·2026
Same author

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Brain : a journal of neurology·2025
Same author

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.

Annals of clinical and translational neurology·2025

Related Experiment Video

Updated: May 2, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

Federated learning for lesion segmentation in multiple sclerosis: a real-world multi-center feasibility study.

Sarah Hindawi1, Bartlomiej Szubstarski2, Eric Boernert3

  • 1Hoffmann-La Roche Limited, Mississauga, ON, Canada.

Frontiers in Neurology
|September 26, 2025
PubMed
Summary
This summary is machine-generated.

Federated learning (FL) enabled secure, collaborative AI for multiple sclerosis (MS) lesion segmentation across multiple hospitals without sharing patient data. This approach shows promise for advancing automated neuroimaging analysis while adhering to privacy regulations.

Keywords:
MRI lesion segmentationdistributed deep learningfederated learningmulti-site trainingprivacy-preserving AI

More Related Videos

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
10:25

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping

Published on: September 25, 2019

49.3K
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K

Related Experiment Videos

Last Updated: May 2, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K
Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
10:25

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping

Published on: September 25, 2019

49.3K
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Multiple sclerosis (MS) is a chronic, disabling neuroinflammatory disease.
  • Accurate segmentation of MS lesions on MRI is vital for disease monitoring and treatment evaluation.
  • Manual segmentation is labor-intensive and variable; automated methods require large, diverse datasets, posing privacy and data-sharing challenges.

Purpose of the Study:

  • To apply and evaluate Federated Learning (FL) for automated multiple sclerosis (MS) lesion segmentation in a real-world clinical setting.
  • To assess the feasibility of using FL to train AI models on distributed datasets without compromising patient privacy.

Main Methods:

  • Utilized the self-configuring nnU-Net model within a Federated Learning framework.
  • Trained the model on 512 MRI cases from three different clinical sites without direct data sharing.
  • Assessed model performance using Dice scores on held-out test sets.

Main Results:

  • The federated model achieved Dice scores between 0.66 and 0.80 across test sets.
  • Performance varied across sites, indicating the impact of data heterogeneity.
  • Demonstrated the potential of FL for scalable and secure AI in distributed neuroimaging.

Conclusions:

  • Federated Learning offers a viable, privacy-preserving method for developing robust AI tools for MS lesion segmentation.
  • This approach facilitates collaborative AI development in neuroimaging, addressing data privacy and regulatory concerns.
  • Supports the adoption of secure, collaborative AI for medical research and clinical applications.